Quick Answer
STERIS plc reported R&D Expense of $107.65 million for fiscal year 2025.
STERIS plc R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $107.65M | +3.8% |
| 2024 | $103.68M | +5.3% |
| 2023 | $98.48M | +13.6% |
| 2022 | $86.66M | +30.7% |
| 2021 | $66.33M | +1.2% |
| 2020 | $65.55M | +4.0% |
| 2019 | $63.04M | +3.7% |
| 2018 | $60.78M | +2.3% |
| 2017 | $59.40M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $29.50M | +7.7% | +4.6% |
| September 30, 2025 | $28.20M | +4.4% | +6.8% |
| June 30, 2025 | $26.40M | +3.1% | -3.6% |
| December 31, 2024 | $27.40M | +8.5% | +1.5% |
| September 30, 2024 | $27.00M | +2.8% | +5.5% |
| June 30, 2024 | $25.60M | +3.7% | +1.4% |
| December 31, 2023 | $25.25M | -1.0% | -3.9% |
| September 30, 2023 | $26.27M | +5.4% | +6.4% |
- STERIS plc showed an increase of +3.8% in R&D Expense compared to the prior fiscal year.
- Over the 2017–2025 period, STERIS plc’s r&d expense has grown by 81.2% (from $59.40 million to $107.65 million).
- The most recent figure is from STERIS plc’s fiscal year 2024 report (Form 10-K), filed with the SEC on May 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: